Public support for regulations around warning labels and marketing restrictions raises stakes for food brands’ messaging strategies.

Providers need to reconcile the tension between nutrition and traditional medicine for patients who view them as competing forces.

The CDC’s new guidance muddles what’s essential, risking more missed or delayed shots.

Approved vaccines for infants to protect against a serious respiratory disease called RSV are getting new scrutiny from federal health agency officials, according to Reuters. Heightened federal scrutiny adds uncertainty for RSV manufacturers at a time when the childhood vaccine environment is already polarized.

The FDA sent another batch of warning letters to direct-to-consumer pharma advertisers, adding healthcare professional marketing to its list of complaints. Marketers should prepare for more intense medical and legal review checks, but also expand beyond brand messaging rather than pullback on the key HCP prescriber audience.

Tylenol maker Kenvue is preparing for a government report that may link Tylenol to autism. The company must counter misleading claims by running targeted awareness campaigns. It can partner with influencer marketing agencies to feature women who used Tylenol during pregnancy and doctor-moms. Kenvue's messaging should highlight study data that confirms there is no proven link between Tylenol and autism.

The trend: US consumers are losing faith in most components of the healthcare system, including federal health agencies and their leaders, drugmakers, insurers, and hospitals. Our take: Marketers at healthcare and pharma organizations (including providers, insurers, public health agencies, and drugmakers) must develop strategies to rebuild trust and guide patients to reliable information during a time of great uncertainty. Vaccine makers should partner with trusted medical groups, local physicians, and pharmacists to develop educational materials with clinical data that counter vaccine hesitancy among consumers. Pharma companies and insurers should address consumer frustrations through open public dialogue and provide transparent explanations for controversial pricing decisions. Drugmakers should additionally monitor condition-specific forums and social platforms like Reddit, where consumers share treatment experiences, and use these spaces to offer cost-saving tools for pricey medications.

The news: HHS Secretary Robert F. Kennedy Jr. is reviving a children’s vaccine task force after pressure from anti-vaccine advocates. The reinstated Task Force on Safer Childhood Vaccines will be led by NIH director Jay Bhattacharya and include FDA and CDC senior officials. Our take: The HHS’ vaccine moves will stoke already growing vaccine hesitancy and mistrust. Healthcare providers and vaccine makers need to ally with medical groups and experts to double down on the proven science of vaccines in clear and reassuring communications to parents and consumers. They should underscore the importance of preventive vaccines for individual children and broader public health.

The news: The identified gunman in a fatal shooting at the CDC’s Atlanta headquarters had blamed the COVID-19 vaccine for making him ill and suicidal, according to media reports. Our take: Building trust in government health agencies like the CDC is crucial. Physician associations and healthcare and pharma companies can help reinforce the credibility of the medical establishment by partnering with trusted local doctors, pharmacists, and patient advocacy organizations to inform consumers on the benefits of government-endorsed treatments and the risks of being unvaccinated.

The news: Several leading medical associations representing hundreds of thousands of US clinicians, as well as scientists, researchers, and public health workers, have sued HHS Secretary Robert F. Kennedy Jr. and other top health officials over the government’s recent decision to make COVID-19 vaccines more restrictive. The big takeaway: Kennedy is running out of allies in the medical and pharma communities. If nothing else, the lawsuit could force Kennedy and his team to adhere to the legal framework in place for making sudden changes that disrupt the public’s access to vaccines.

The news: During a Congressional subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. laid out his vision for all Americans to use a wearable with health-tracking capabilities within four years. Our take: Marketers should use Kennedy’s enthusiasm for wearables to their advantage. They should get out in front of the government’s ad campaign by developing their own promotions that inform consumers of wearables’ evolved health-tracking features beyond just counting calories and steps. They could target people who aren’t as familiar or have never used a health wearable due to price concerns or lack of tech-savviness.

The news: HHS Secretary Robert F. Kennedy Jr. replaced the CDC’s influential vaccine advisory board with 8 new members, including some anti-vaccine advocates. Our take: The new HHS administration's public statements and actions undermine the safety perception of all vaccines. Drugmakers on the sidelines risk consumer trust—and vaccine uptake. It’s time to partner with respected medical groups like AMA to counterbalance confusion.

The news: Avidity Biosciences struck a deal with the FDA for accelerated approval of a treatment for a rare type of muscular dystrophy. Our take: The Avidity announcement and federal health agency enthusiasm are positive signs for biotech and pharma companies looking for accelerated approval for rare disease candidates. Federal authorities and drugmakers will need to balance speed-to-market with rigorous science to ensure physician and consumer confidence.

Trump admin invests $500M for universal vaccine project: Perhaps the administration isn’t as anti-vax as publicly perceived. However, vaccine makers are still on high alert as approval timelines for vaccines undergoing trials could get pushed back.

HHS instructs CDC to shelve vaccine ads, including for the flu: RFK Jr. was at the helm of a decision to halt the CDC’s vaccine-focused advertisements—an early indicator of the steps he’s willing to take in his new role as HHS Secretary.

Oregon bill seeks to ban AI nurses: If passed, the bill could provide a framework for other states as they work to regulate the use of AI in healthcare settings.

Chaos reigns at federal health agencies: Communications pauses, funding freezes, and fraud investigations have all taken place in recent weeks. Here’s why the flurry of activity holds serious implications for the future of the NIH, CDC, and CMS.

New York attorney general tells hospitals to continue gender-affirming care: The mandate stands in opposition to President Trump’s recent executive order that outlaws gender-affirming care in children, with hospitals’ access to federal funding on the line.

RFK Jr.’s HHS Secretary nomination advances: If there were any lingering concerns over Kennedy leading the department, Senator Cassidy—a physician—and his deciding vote likely put them to rest.